Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision
Colorectal cancer (CRC) is one of the most common types of cancer in the world. Metastatic disease is still incurable in most of these patients, but the survival rate has improved by treatment with novel systemic chemotherapy and targeted therapy in combination with surgery. New knowledge of its com...
Main Author: | Rebersek Martina |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2020-05-01
|
Series: | Radiology and Oncology |
Subjects: | |
Online Access: | https://doi.org/10.2478/raon-2020-0031 |
Similar Items
-
RDMS CMS computing: current status and plans
by: V. B. Gavrilov, et al.
Published: (2015-06-01) -
Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine
by: Manish Pratap Singh, et al.
Published: (2021-03-01) -
JINR TIER-1-level computing system for the CMS experiment at LHC: status and perspectives
by: N. S. Astakhov, et al.
Published: (2015-06-01) -
Interconnectivity between molecular subtypes and tumor stage in colorectal cancer
by: R. R. J. Coebergh van den Braak, et al.
Published: (2020-09-01) -
Engineering the morphology of carbon molecular sieve (CMS) hollow fiber membranes
by: Bhuwania, Nitesh
Published: (2015)